Literature DB >> 15747611

Future treatment of osteoarthritis.

Champ L Baker1, Cristin M Ferguson.   

Abstract

Osteoarthritis represents an advanced stage of disease progression caused in part by injury, loss of cartilage structure and function, and an imbalance in inflammatory and noninflammatory pathways. The burden of this disease will increase in direct proportion to the increase in the older adult population. Research on current and experimental treatment protocols are reviewed, including the effect of hyaluronic acid in both in vitro and in vivo studies, autologous chondrocyte and osteochondral plug implantation, and gene therapy. Disease-modifying osteoarthritis drugs and in vivo studies of glucosamine and chondroitin sulfate are reviewed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15747611     DOI: 10.3928/0147-7447-20050202-08

Source DB:  PubMed          Journal:  Orthopedics        ISSN: 0147-7447            Impact factor:   1.390


  5 in total

Review 1.  Immunological activity of chondroitin sulfate.

Authors:  Toshihiko Toida; Shinobu Sakai; Hiroshi Akiyama; Robert J Linhardt
Journal:  Adv Pharmacol       Date:  2006

2.  Anti-inflammatory and chondroprotective effects of atorvastatin in a cartilage explant model of osteoarthritis.

Authors:  Nitya N Pathak; Madhu C Lingaraju; Venkanna Balaganur; Vinay Kant; Amar S More; Dhirendra Kumar; Dinesh Kumar; Surendra K Tandan
Journal:  Inflamm Res       Date:  2015-01-18       Impact factor: 4.575

3.  Managing joint pain in osteoarthritis: safety and efficacy of hylan G-F 20.

Authors:  Augustine H Conduah; Champ L Baker; Champ L Baker
Journal:  J Pain Res       Date:  2009-07-06       Impact factor: 3.133

Review 4.  LncRNA MALAT1 promotes osteoarthritis by modulating miR-150-5p/AKT3 axis.

Authors:  Ying Zhang; Fuyou Wang; Guangxing Chen; Rui He; Liu Yang
Journal:  Cell Biosci       Date:  2019-07-01       Impact factor: 7.133

5.  The effectiveness of pulsed electrical stimulation (E-PES) in the management of osteoarthritis of the knee: a protocol for a randomised controlled trial.

Authors:  Robyn E Fary; Graeme J Carroll; Tom G Briffa; Ritu Gupta; N Kathryn Briffa
Journal:  BMC Musculoskelet Disord       Date:  2008-02-04       Impact factor: 2.362

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.